MediSensonic

MediSensonic SA is a Polish MedTech company founded in 2018, specializing in non-invasive diagnostic devices.

Headquartered in Wrocław, with a secondary address in Warsaw, the company is publicly traded on the Warsaw Stock Exchange as of late 2024. MediSensonic employs 11 to 50 people and has raised approximately $3.17 million in funding, with support from the Medical Research Agency. The company develops innovative solutions using microwave, photo-optical, and artificial intelligence technologies. Its product lineup includes the Glucowave, a needle-free wristband for continuous blood glucose monitoring; the MPVT, a non-invasive dental pulp vitality tester; and Touchwave, a blood pressure sensor that operates without a traditional cuff. MediSensonic's devices target various medical fields, including diabetology, dentistry, and cardiology, aiming to improve patient care through precise and painless diagnostic methods. The company validates its products through clinical trials to ensure accuracy and effectiveness.